Press Releases

Form 8.5 (EPT/RI) - FireAngel Safety Technology Group Plc Jun 3, 2024 03:39AM

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)        Name of exempt principal trader:Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each... (continue reading...)

Repurchase of Truecaller B shares in week 22, 2024 Jun 3, 2024 03:39AM

STOCKHOLM, June 3, 2024 /PRNewswire/ -- During 28 May 2024 and 31 May 2024 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 250,000 own B shares (ISIN: SE0016787071) as part of the share buyback programme initiated by the board of directors.

The share buybacks form part of the share buyback programme announced by Truecaller on 28 May 2024. The share buyback programme will run between 28 May up until the 2025 AGM, which will be held in... (continue reading...)

Form 8.5 (EPT/RI) - NewRiver REIT Plc Jun 3, 2024 03:31AM

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)        Name of exempt principal trader:Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each... (continue reading...)

Virgin Media Ireland picks Cerillion for major transformation deal Jun 3, 2024 03:30AM

LONDON, June 3, 2024 /PRNewswire/ -- Cerillion (AIM: CER), a leading provider of BSS/OSS-as-a-Service solutions to the telecoms industry, today announced that it is working with Virgin Media Ireland, the leading connected entertainment cable and broadcast business in Ireland. Cerillion is implementing its pre-integrated BSS/OSS suite to help Virgin Media Ireland simplify and automate its operations for its broadband and mobile customer base, whilst accelerating... (continue reading...)

STORM Therapeutics Presented Interim Phase 1 Clinical Data on its METTL3 RNA Methyltransferase Inhibitor STC-15 at ASCO 2024 Jun 3, 2024 03:30AM

STC-15 was well tolerated and clinical activity was observed across the pharmacologically active dose range in advanced cancer patients

Primary objectives were achieved to progress STC-15 into combination with checkpoint inhibitor combination studies

CAMBRIDGE, England, June 3, 2024 /PRNewswire/ -- STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announces that interim Phase... (continue reading...)